Alzamend Neuro EPS ALZN
Diluted earnings per share by quarter and over the last twelve months, from 2020.
- Last 12 months, to Jul 31, 2026
- −$2.28
- Latest quarter, Q1 FY27
- −$0.68
- Fiscal year 2026
- −$2.88
Alzamend Neuro's earnings per share was −$2.28 over the twelve months to Jul 31, 2026.
In its latest quarter, Q1 FY27, it was −$0.68.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2026 | −$2.88 | n/a |
| FY2025 | −$19.05 | n/a |
| FY2024 | −$133.91 | n/a |
| FY2023 | −$204.30 | n/a |
| FY2022 | −$189.00 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q1 FY27 | −$0.68 | n/a | −$2.28 | |
| Q4 FY26 | −$0.72 | n/a | −$2.88 | |
| Q3 FY26 | −$0.58 | n/a | −$4.43 | |
| Q2 FY26 | −$0.30 | n/a | −$5.60 | |
| Q1 FY26 | −$1.28 | n/a | −$8.91 | |
| Q4 FY25 | −$2.27 | n/a | −$19.05 | |
| Q3 FY25 | −$1.75 | n/a | −$28.47 | |
| Q2 FY25 | −$3.61 | n/a | −$60.65 | |
| Q1 FY25 | −$11.42 | n/a | −$96.91 | |
| Q4 FY24 | −$11.69 | n/a | −$133.91 | |
| Q3 FY24 | −$33.93 | n/a | −$168.12 | |
| Q2 FY24 | −$39.87 | n/a | −$208.89 |
Against its peers
Companies in Healthcare nearest Alzamend Neuro's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| ALZNAlzamend Neuro | −$2.28 | |
| OXBROXBRIDGE RE HOLDINGS | $0.02 | |
| EDUCEducational Development | $0.19 | |
| GTIMGood Times Restaurants | $0.21 | +75% a year |
| MDRRMedalist Diversified | $3.84 | |
| BCGBinah Capital | $0.16 | |
| VIPVulcan Infrastructure & Power | $0.07 | |
| MXCMexco Energy | $0.75 | −5% a year |
| CKXCKX Lands | $1.42 | +647% a year |
| MSGMMotorsport Games | $0.43 | +187% a year |
| ATCHAtlasClear | $0.01 | |
| Peer median | $0.20 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Alzamend Neuro
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.